Abstract
THE clinical evaluation of new antibacterial agents has resulted in varied recommendations for treatment of meningococcal infection.1 2 3 4 Clinical response to sulfonamides5 6 7 is superior to that with penicillin,8 9 10 11 12 13 and it has also been demonstrated that chloramphenicol3 and the tetracyclines14 are effective against this organism. In addition to antibacterial agents various supportive measures such as vasopressor agents and steroids are thought to be of value. Case reports2 suggest that a number of patients with the Waterhouse–Friderichsen syndrome have survived because of their use. With these facts in mind all records of patients with meningococcal infection admitted to the Los Angeles Children's Hospital . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.